Home

The Korea Herald

Latest news

Most Popular

  1. 1

    1 in 3 Koreans live alone, family types becoming diverse

    1 in 3 Koreans live alone, family types becoming diverse
  2. 2

    Korea, Japan finance chiefs vow to tame rampant FX market volatility

    Korea, Japan finance chiefs vow to tame rampant FX market volatility
  3. 3

    US 'incredibly concerned' about suspected NK-Iran military ties

    US 'incredibly concerned' about suspected NK-Iran military ties
  4. 4

    K-pop group's manager dismissed for setting up spycam in theater dressing room

    K-pop group's manager dismissed for setting up spycam in theater dressing room
  5. 5

    K-pop singer lost consciousness after being hit by foul ball, cancels show

    K-pop singer lost consciousness after being hit by foul ball, cancels show
  1. 6

    Korean Muslim YouTuber's plan to build mosque in Incheon goes viral

    Korean Muslim YouTuber's plan to build mosque in Incheon goes viral
  2. 7

    Why is Apple Pay struggling to get purchase in Korea?

    Why is Apple Pay struggling to get purchase in Korea?
  3. 8

    Yoon's office denies considering liberal figures for key posts

    Yoon's office denies considering liberal figures for key posts
  4. 9

    Seoul says Fu Bao loan 'not going to happen'

    Seoul says Fu Bao loan 'not going to happen'
  5. 10

    [Today’s K-pop] BTS pop-up event to come to Seoul

    [Today’s K-pop] BTS pop-up event to come to Seoul
피터빈트

S. Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development

By Yonhap

Published : July 20, 2022 - 11:54

    • Link copied

This photo provided by the National Institute of Infectious Diseases (NIID) on Wednesday, shows (from L to R) NIID head Jang Hee-chang, National Institute of Health chief Kwon Jun-wook and Paul Burton, chief medical officer of Moderna Inc., at a signing ceremony for vaccine collaboration agreement held at the Korea Disease Control and Prevention Agency in Sejong, central South Korea. (NIID) This photo provided by the National Institute of Infectious Diseases (NIID) on Wednesday, shows (from L to R) NIID head Jang Hee-chang, National Institute of Health chief Kwon Jun-wook and Paul Burton, chief medical officer of Moderna Inc., at a signing ceremony for vaccine collaboration agreement held at the Korea Disease Control and Prevention Agency in Sejong, central South Korea. (NIID)

South Korea's state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna Inc., a US biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS).

The institute said the deal, signed Monday, was its first joint project agreement with an overseas pharmaceutical company. The institute said it expects the research to help elevate the center's research capacity.

Caused by viral infections, SFTS has a high fatality rate, but there is no preventive vaccine or therapeutic agent as of now.

Paul Burton, Moderna's chief medical officer, said the company plans to develop 15 vaccines by 2025, including infectious diseases that threaten global health but still remain largely unnoticed by the public.

Burton said the collaboration with the NIID was significant for serving as an important part of delivering on Moderna's promise of developing new vaccines. (Yonhap)

More from Headlines